Figure 4

Kaplan–Meier analysis for 90-day survival probability in ARDS patients receiving ECMO support according to initial IL-10 levels and RESP scores. ARDS patients with higher plasma IL-10 levels at day 0 (a) and lower RESP scores (b) before ECMO implementation were associated with significantly worse survival.